NCT02372240View on ClinicalTrials.gov

A Study of VLX1570 and Dexamethasone in Myeloma Patients

PHASE1/PHASE2TerminatedINTERVENTIONAL

Enrollment

15

Participants

Timeline

Start Date

April 8, 2015

Primary Completion Date

May 24, 2017

Study Completion Date

May 24, 2017

Conditions

Multiple Myeloma

Interventions

DRUG

VLX1570 and dexamethasone

Trial Locations (1)

10065

Memorial Sloan Kettering Cancer Center, New York

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Theradex

INDUSTRY

lead

Vivolux AB

INDUSTRY